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Abstract
The disease-linked amyloid β (Aβ) and α-synuclein (αS) proteins are both ﬁbril-forming and natively unfolded in
free monomeric form. Here, we discuss two recent studies, where we used extensive implicit solvent all-atom Monte
Carlo (MC) simulations to elucidate the conformational ensembles sampled by these proteins. For αS, we somewhat
unexpectedly observed two distinct phases, separated by a clear free-energy barrier. The presence of the barrier makes
αS, with 140 residues, a challenge to simulate. By using a two-step simulation procedure based on ﬂat-histogram
techniques, it was possible to alleviate this problem. The barrier may in part explain why ﬁbril formation is much
slower for αS than it is for Aβ.
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1. Introduction
The mechanisms by which proteins misfold and aggregate into oligomers and ﬁbrils are currently the subject
of intense research [1]. This research aims, in particular, at improving our understanding of the molecular basis of
protein-misfolding diseases, such as Alzheimer’s and Parkinson’s diseases. Knowledge of the underlying mechanisms
is further a prerequisite for rational development of strategies to prevent protein aggregation [2].
Computer simulations are an indispensable complement to experiments in unraveling the complex processes of
protein misfolding and aggregation. Diﬀerent computational approaches are being used, at varying levels of detail.
Coarse-grained models are useful, for instance, for studying generic features of ﬁbril formation [3]. Such studies
have, in particular, provided insights into the factors governing ﬁbril nucleation; ﬁbril formation typically show sig-
moidal kinetics with a lag phase, indicating a nucleation-dependent process. The precise nature of the aggregation
process, including the rate at which it occurs, varies widely from protein to protein. Studies of speciﬁc proteins are
typically based on atomically detailed models, with or without explicit solvent [4]. This approach is computation-
ally challenging, but has been used to investigate early events in the aggregation process for some small proteins,
like the Aβ protein associated with Alzheimer’s disease [5, 6]. Atomic-level simulations were further used to study
the incorporation of monomers into growing ﬁbrils [7] as well as the mode of action of aggregation-inhibiting small
molecules [8].
Using MC techniques, we recently studied the natively unfolded monomeric forms of two ﬁbril-forming and
disease-linked proteins, namely Aβ [5], with 42 residues, and the 140-residue αS protein associated with Parkinson’s
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Figure 1: Snapshots showing typical low-energy conformations for the system of 8 GIIFNEQ peptides. The structures share an overall β-sandwich
topology, but diﬀer in the organization of the strands. Drawn with PyMOL [23].
disease [9]. For Aβ, we also studied dimer formation [6]. The present article summarizes and compares the ﬁndings
of these studies.
Both proteins were studied using the same implicit solvent all-atom force ﬁeld [10, 11], but the simulation methods
were somewhat diﬀerent. For Aβ, we used the convenient simulated tempering method, which is similar in spirit and
performance to the widely used replica exchange or parallel tempering method. αS was more challenging to study, in
part because of its larger size, but also because of a clear two-phase behavior. To facilitate crossing the rather large
free-energy barrier separating these phases, we changed scheme from simulated tempering to a two-step procedure
based on ﬂat-histogram techniques [12].
2. Model and algorithms
All simulations discussed in this article are based on the same implicit solvent all-atom model, with torsional
degrees of freedom [10, 11, 13]. In short, the potential is composed of four terms, E = Eloc + Eev + Ehb + Esc. The
ﬁrst term, Eloc, contains local interactions between atoms separated by only a few covalent bonds. The other three
terms are non-local in character: Eev represents excluded-volume eﬀects, Ehb is a hydrogen-bond potential, and Esc
describes residue-speciﬁc interactions, based on hydrophobicity and charge, between pairs of side chains.
This potential was developed through folding thermodynamics studies of a structurally diverse set of peptides
and small proteins, while deliberately keeping it as simple as possible [11]. It is worth stressing that the same set of
parameters is used for α, β, as well as mixed α/β proteins. The model has previously been applied to study the folding
of peptides and small proteins [11, 14] as well as the aggregation of small peptides [15–18].
Our studies are carried out using MC methods. Three elementary conformational moves are employed: (i) pivot-
type rotations about individual backbone bonds, (ii) a semi-local backbone update, Biased Gaussian Steps, which
rotates up to eight consecutive angles simultaneously [19], and (iii) rotations of individual side-chain angles. For
multi-chain systems, we also include rigid-body translations and rotations of whole chains relative to each other. This
model and these algorithms are implemented in the open source package PROFASI [20].
As indicated above, to speed up our αS simulations, we used ﬂat-histogram techniques. The procedure was
ﬁrst tested on a system consisting of 8 copies of a 7-residue fragment, GIIFNEQ, of the superoxide dismutase 1
protein [12]. In our simulations of this system, two distinct phases (aggregated/non-aggregated) occurred, separated
by a clear free-energy barrier. Figure 1 illustrates the aggregated phase by three representative snapshots from the
simulations. The fact that the aggregated structures are β-sheet-rich is consistent with results from the aggregation
prediction program Waltz [21], which suggests this part of the SOD1 protein to be particularly prone to form amyloid
structure [22].
The employed ﬂat-histogram procedure assumes that the system of interest undergoes a ﬁrst-order-like phase tran-
sition, at which the energy distribution is bimodal. It amounts to ﬁrst constructing and then simulating a generalized
ensemble deﬁned by the microstate probability distribution




1/g(Eν) if E1 ≤ E ≤ E2
exp(−Eν/RTm) otherwise (1)











Figure 2: Schematic illustration of the simulated ensemble. It is assumed that the system of interest displays a ﬁrst-order-like phase transition, at
which the energy distribution, Pcan(E), is bimodal. The peaks are centered at E1 and E2. The energy distribution for the simulated ensemble, P(E),
is ﬂat in the coexistence region E1 < E < E2, while P(E) ∝ Pcan(E) outside this range.
where g(E) is the density of states, and E1 and E2 denote the positions of the energy distribution peaks at the midpoint
temperature Tm (R is the gas constant). Figure 2 shows the corresponding energy distribution, P(E), which is ﬂat
between E1 and E2 in order to facilitate transitions between the low- and high-energy phases. Outside this range,
P(E) falls oﬀ like the canonical energy distribution. The exact shape of the tails of P(E) is unimportant. The main
point is to avoid unnecessary sampling of the bottom part of the energy landscape, which may consist of narrow
minima that are diﬃcult to sample and not necessarily low in free energy. Otherwise, one risks slowing down the
simulations through a time-consuming exploration of narrow minima with a negligible occupancy at biologically
relevant temperatures.
The ﬁrst step of the procedure is to estimate the function γ(E), which is accomplished by means of the Wang-
Landau method [24, 25]. The second step is to simulate the ensemble Pν = 1/γ(Eν) by standard techniques, which
corresponds to a multicanonical production run [26, 27]. Finally, properties of the original system are recovered by
reweighting methods [28].
Figure 3 shows the MC time evolution of the energy in typical runs with this method for the system of 8 GGIINEQ
peptides. For comparison, a constant-temperature simulation is shown as well. The transition frequency between the
aggregated and non-aggregated phases is low in the conventional canonical simulation. The mobility of the system is
improved in the 1/γ ensemble.
In our runs, this system displayed a strong and to us unanticipated preference for α- over β-structure for large
values of the Wang-Landau modiﬁcation factor f . The formation of β-structure, which requires the establishment of
long-range contacts, seemed to be hampered by the bias away from the last visited region present at large f . This
property might be general and show up in simulations of other protein systems as well. Because of this property, we
found it advantageous to start the simulations with a relatively small initial f (ln f = 2−10 rather than ln f = 1).
Our αS study was performed using the above scheme. In the production runs, transitions between the high-
and low-energy phases occurred with comparable frequencies in both directions. Because of this property, we can
compare the two coexisting phases in an unbiased manner. This behavior was not achieved in preliminary runs with
the replica exchange method. The statistics did not permit, however, a statistically accurate determination of the
relative population of the two phases as a function of temperature. Furthermore, we do not expect the temperature
scale of current force ﬁelds to be perfect. Our αS study therefore focused on single-phase properties, which are
statistically easier to determine and depend much more weakly on temperature, compared to the relative weight of the
phases.
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Figure 3: MC time evolution of the energy in typical runs with three diﬀerent methods for the system of 8 GFIINEQ peptides. The right panel shows
histograms of energies visited in the respective runs. (a) Wang-Landau simulation, (b) simulation of the 1/γ ensemble (see Eq. 1 and Figure 2), and
(c) canonical-ensemble simulation at a temperature T ≈ Tm.
3. Comparing Aβ and αS ensembles
Aβ occurs in two main forms, Aβ40 and Aβ42, with 40 and 42 residues, of which Aβ42 is most strongly linked to
Alzheimer’s disease. In ﬁbrils, each Aβ molecule participates in two intermolecular face-to-face packed β-sheets [29,
30]. The two β-regions are connected by a loop at residues ∼25–30.
In our study, we investigated Aβ42 monomers [5] and dimers [6]. We studied the wild-type protein as well as the
mutants E22G, E22G/I31E and F20E. These variants were deliberately chosen so as to have very diﬀerent aggregation
properties [31]. The E22G mutation, associated with a familial early-onset form of Alzheimer’s disease, is known to
enhance aggregation, whereas the F20E mutation has the reverse eﬀect. The double mutant E22G/I31E shows more
complex aggregation properties. Its propensity to form ﬁbrils is almost as high as that of the E22G variant, whereas
its propensity to form preﬁbrillar species is only slightly higher than that of F20E.
These Aβ42 variants all displayed large conformational variability and similar overall properties in the simulations.
Typical conformations were compact and had a signiﬁcant β-strand content. Diﬀerences among the variants could also
be seen, especially in the ﬁbril loop region. Interestingly, the propensity with which this part of the molecule formed
a ﬁbril-like turn was found to correlate with the experimental rate of ﬁbril formation. Moreover, the probability of
observing a ﬁbril-like turn increased upon dimer formation.
There are several lines of evidence suggesting that the formation of this loop is a key step in ﬁbrillation. For
instance, it was shown that the coupling of residues 23 and 28 through a lactam bridge, to enforce a ﬁbril-like turn,
leads to much faster ﬁbril formation [32]. Our ﬁndings support this picture, by suggesting that ﬁbrillation-modulating
mutations indeed cause conformational changes in this part of the molecule.
While there is recent evidence indicating that αS has a folded helical tetramer as its main physiological form [33],
it is well established that free monomeric αS is highly disordered [34]. In αS ﬁbrils, the stretch from residue ∼ 35
to ∼ 98 is thought to form ﬁve strands, which belong to separate (intermolecular) β-sheets that are stacked upon each
other [35]. This makes the ﬁbril core structure somewhat reminiscent of that of Aβ ﬁbrils.
In our simulations of the free αS monomer [9], two distinct phases occurred, schematically illustrated in Figure 4.
These were a disordered high-energy phase, called D, and a low-energy phase, B. The latter phase had a signiﬁcant
β-strand content, but nevertheless large conformational variability. We analyzed secondary-structure propensities, size
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Figure 4: Schematic free-energy landscape for the αS monomer.
and topological properties of these two phases, and compared with existing experimental data, mainly from NMR-
based studies.
The properties of the D phase matched very well with the ﬁndings of numerous experiments at neutral pH and tem-
peratures typically around 15◦C. This agreement shows, in particular, that the B phase can only be weakly populated
under such conditions. Presence of the B phase is, by contrast, compatible with data from low-temperature experi-
ments (−15◦C and −10◦C). These data cannot be explained by either the D or the B phase alone, but are consistent
with a mixture of the two phases. The B phase fraction required to match the data could be as high as 50–70%.
A closer analysis of the B phase reveals that the β-sheets tend to have a simple meander topology, and that the
sequence locations of the strands correlate with those in αS ﬁbrils [35]. These two properties imply that the backbone
fold resembles that found in the core of ﬁbrils [35]. This similarity does not necessarily mean that a monomer in the
B phase can easily get incorporated into a growing ﬁbril, because in-plane intramolecular hydrogen bonds are to be
replaced by out-of-plane intermolecular ones. The two-phase behavior has, nevertheless, implications for aggregation.
A comparison of our αS and Aβ results illustrates this point. Both monomers populated ﬁbril-like folds in the
simulations. For αS, we observed a two-phase behavior, where only the B phase showed ﬁbril-like features. In the D
phase, the monomer must overcome a free-energy barrier to acquire a ﬁbril-like fold. This contrasts sharply with our
ﬁndings for Aβ, which has only a single phase and no corresponding barrier. These results are perfectly consistent
with the experimental fact that aggregation is much slower for αS than it is for Aβ [36, 37].
We ﬁnd the above results very encouraging and will extend our studies of both Aβ and αS. For instance, it would
be very interesting to study the eﬀects of aggregation-inhibiting small molecules on Aβ and αS, and how individual
monomers bind to a growing ﬁbril. These problems are computationally feasible but demanding — there is no doubt
room for further improvements of both models and algorithms.
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